CSI Market
Sign In | Register

Mersana Therapeutics inc (MRSN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MRSN Annual Balance Sheets →
From Mersana Therapeutics inc through Sep 30 2024, shifts in Sep 30 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent56.39
Cash & Short-term Investments56.00
Accounts receivable0.17
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.43
Total Current Assets59.99
Other Assets, Noncurrent1.00
Debt Securities Available For Sale Excluding Accrued Interest-
Operating Lease Right Of Use Asset2.04
Total Assets62.69
Liabilities
Accounts Payable, Current AC2.39
Accrued Liabilities, Current AC14.81
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current26.06
Total Current Liabilities43.27
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent78.95
Operating Lease Liability Current2.29
Operating Lease Liability Noncurrent-
Contract With Customer Liability Noncurrent78.95
Total Liabilities122.22
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock891.98
Retained Earnings / Accumulated Deficit-951.52
Other Equity0.00
Common Stockholder's Equity-59.54
Total Stockholder's Equity-59.54
Liabilities & Stockholder's Equity62.69
4 historic quarters locked

Sign in to unlock the full Mersana Therapeutics inc balance sheet history.

Sign In Create Free Account

About Mersana Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250930)
  • Filed with the SEC: November 14, 2025
  • Source: mrsn-20250930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-25-052202

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.